Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. - Wikidata - wikimedia - TriplyDB

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35537270

about

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Self management for patients with chronic obstructive pulmonary disease Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial Sleep in Chronic Obstructive Pulmonary Disease: Evidence Gaps and Challenges Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis Efficacy and safety of conventional long acting β2- agonists: systematic review and meta-analysis Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA Roflumilast: a review of its use in the treatment of COPD Chronic obstructive pulmonary disease: respiratory review of 2013 Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review Mucociliary clearance: pathophysiological aspects Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach Cadmium attenuates the macrophage response to LPS through inhibition of the NF-κB pathway Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.A score to predict short-term risk of COPD exacerbations (SCOPEX).Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review.Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.Impact of patient characteristics, education and knowledge on emergency room visits in patients with asthma and COPD: a descriptive and correlative study.Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics.Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments "Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD.Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.PURLs: Should you consider antibiotics for exacerbations of mild COPD?Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study Chronic obstructive pulmonary disease exacerbations: accurate and easy measurement promises much

P2860

Q24187361-9141BB05-B2A0-4CDC-9F9B-1759D9F5979B Q24193908-EFE3B814-23D9-4E3A-AA83-E4A1E2BFECBD Q24197903-232A3681-C32F-407B-814B-56268E1950FC Q24629954-44C4A895-AFB5-48BD-BB54-D22211842D7D Q26738475-A3AA9433-0BEE-4076-8C2E-6008D036FF54 Q26740229-C5D550DD-6872-48C6-82E8-5D96591C5E35 Q26744161-443FC91D-6DEC-427B-8DE6-691ED3994949 Q26752988-61A10EC6-74E8-47C5-9FDA-ABE638223AE3 Q26770501-5D8D6FAC-4E2C-427D-B93C-F689B989FC59 Q26864703-BB8DD129-4A75-4E12-92F0-1C4F1EFF50C9 Q27000043-AE4375F3-0977-4AA3-A8DF-0E33AE1FF5DD Q27015685-D3EF95D4-3B44-4D7D-BDCD-920C1C37EAA4 Q27022272-DC617A9D-6210-4D06-8796-3587763A46AA Q27025647-0D5C39AA-93B4-4E0D-B251-C4384E7DFC6E Q27026708-56DBC124-5F0D-48E3-BDB1-7042044993E8 Q27317947-34E55FB5-C57C-4FC4-B5FD-DBA43B4C9E24 Q28070274-2B6DF49A-0310-496C-9C53-5F7DD1F03822 Q28392320-DC118725-A6A7-4820-BE57-FF927F9A148D Q28396001-ED9F3AF3-80B5-4449-AEA2-57993C35E5F8 Q28535004-9E674FD5-5EE5-4BCA-BCEC-18D9DFA294C8 Q30238816-55261945-9EC7-4FB9-B833-F69F77EFD1CE Q30371420-F544A871-EEB1-4599-9E8C-471CF29C842C Q30619543-3B4042BE-9D6C-488C-BEDF-D71E937B2E32 Q30828471-1D4732F6-46FC-4922-AB6B-761FDA91926A Q31042243-EBD92D2D-5618-4E03-8302-F30D6AF7CD31 Q33317002-164389C8-19E5-4361-A5A0-7AD8DA7FE5B8 Q33398817-41CBC7DC-65D1-45CF-A913-05BF5EE47942 Q33491797-EF51D82C-C9F5-45F4-B2F5-99698BE4052C Q33500680-6EEA586A-BE4C-493B-850C-CEE5B4E94165 Q33521100-CE1CB598-1F8A-4DCC-8628-4395FB671C50 Q33585772-EED30A0F-8F05-4BD0-A2BB-00107EB866AB Q33591899-0BA14C4C-1B1E-4C95-9F0D-27693C1B5C93 Q33596502-D4862998-F158-497D-A638-86921559D7E7 Q33615415-C4DDDB2A-506C-4499-9887-FFE987DD9B7B Q33693227-08CCBEBF-6E2D-4224-BB02-DEA1CF1515E3 Q33698659-F25AF274-6D33-45BE-9D31-43116C070C8F Q33703968-DE77D78A-2141-4660-95CA-B0A36CABCD89 Q33711672-A10E400F-C39F-4DA2-A920-59FDF14884DE Q33723544-1B9ECF92-B7D0-449E-85F3-B8B09EC248EE Q33738801-FE1BA86E-4F66-4318-A44E-54FF40DF5818

P2860

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35537270

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Severe acute exacerbations and ...... obstructive pulmonary disease.

@ast

Severe acute exacerbations and ...... obstructive pulmonary disease.

@en

type

label

Severe acute exacerbations and ...... obstructive pulmonary disease.

@ast

Severe acute exacerbations and ...... obstructive pulmonary disease.

@en

prefLabel

Severe acute exacerbations and ...... obstructive pulmonary disease.

@ast

Severe acute exacerbations and ...... obstructive pulmonary disease.

@en

P1433

Q35537270-1EC7753E-501A-46B9-B010-89E2F2272E11

P1476

Q35537270-4E03EC7A-9B11-4D30-8839-5A715C63C0D5

P2093

Q35537270-3071CB6A-9C11-4E53-944A-9F9CC826FEDE

Q35537270-9403B0DB-9C8E-4E1D-A454-970336F3DE58

Q35537270-A88A3827-F7CC-4155-9CCC-28C4639FC736

Q35537270-B923AC9C-D234-4536-9EB2-F58E324F8427

Q35537270-C312D920-0D9D-447D-AADF-65822E621257

P2860

Q35537270-0D4056C8-9389-4D40-A3F0-FC87F1E0FBE6

Q35537270-26758C5E-0788-42D1-A00D-78C39FAFFDAF

Q35537270-3267D111-3BA8-4307-88C7-E2FE8D2DBEA6

Q35537270-3B9FBCAA-6BD4-4465-81EF-250830F52A73

Q35537270-3BB75B8E-4E79-4E5F-9FCD-3A0CD5B56379

Q35537270-3C08953C-1544-4964-AA18-3158C26E6064

Q35537270-3E16597E-CB50-403B-9A4D-4AD288416E26

Q35537270-3F38A2BC-DB72-4024-A27B-1F059DDC1008

Q35537270-47B4E896-4B66-4B09-B730-37837F50C2D8

Q35537270-5140765A-834C-4329-A332-A6BC6C036E6B

P304

Q35537270-03F34AB1-CFF1-4268-ADE9-6A9AF8BD9843

P31

Q35537270-962E9B4F-EDEA-4054-A776-7BC17F2530F1

P356

Q35537270-381C37E0-AD4A-4326-A4F7-FC6E16CF5666

P407

Q35537270-915D3CE2-6201-4028-8156-2F757A6881CD

P433

Q35537270-F62E13E2-F621-471B-9EA8-4EF29F99D531

P478

Q35537270-F63C5F8D-1144-44AF-AE00-39026E420B89

P50

Q35537270-AB71E50A-4559-4DF1-A295-604B13FD613F

P577

Q35537270-A4AD3F53-84C2-432F-BA3B-0ADCB907DF3C

P5875

Q35537270-9E6A7F8D-EB09-4FEE-97DE-8F487824A434

P698

Q35537270-CFFECA11-C85A-4397-B70C-1DE197AB66D2

P921

Q35537270-34B8B254-AA79-4F93-BF7F-D3EDD86D875D

P932

Q35537270-874DDA70-8F0A-4951-8889-74E207918223

P356

THX.2005.040527

P1433

P1476

Severe acute exacerbations and ...... obstructive pulmonary disease

@en

P2093

Martínez-García MA

http://www.w3.org/2001/XMLSchema#string

Ochando R

http://www.w3.org/2001/XMLSchema#string

Román Sánchez P

http://www.w3.org/2001/XMLSchema#string

Salcedo E

http://www.w3.org/2001/XMLSchema#string

Soler-Cataluña JJ

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Erlotinib in previously treated non-small-cell lung cancer

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Pharmacoeconomic evaluation of COPD.

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Spirometric reference values from a Mediterranean population.

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

P304

925-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2005.040527

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7689761

http://www.w3.org/2001/XMLSchema#string

P698

16055622

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1747235

http://www.w3.org/2001/XMLSchema#string